Analyst firms · Morgan Stanley · HBAN

Morgan Stanley HBAN price target and rating history

Huntington Bancshares Incorporated (HBAN) · Finance

Morgan Stanley rates Huntington Bancshares Incorporated (HBAN) Equal-Weight with a $19 price target, as of its latest action on Jul 24, 2026. It has published 5 rating actions on HBAN since December 2021, including 1 upgrade and 1 downgrade. Across 6 firms with a HBAN price target in the last 12 months, the median target is $19. Morgan Stanley's target matches it.

Current rating
Equal-Weight
Price target
$19
Median target, all firms
$19
Actions on HBAN
5

Morgan Stanley price target on HBAN

$19$19$1820222023202420252026
Morgan Stanley price target on HBAN, each point a stated target, December 2021 to July 2026.

Every Morgan Stanley rating on HBAN

How other firms rate HBAN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchPeer PerformOct 27, 2026
TD CowenBuy$18Oct 8, 2026
Wells FargoOverweight$23Aug 17, 2026
BofA SecuritiesNeutral$18.50Jul 27, 2026
Morgan StanleyEqual-Weight$19Jul 24, 2026
JefferiesHold$19Jul 6, 2026
StephensEqual-WeightJun 15, 2026
Evercore ISIOutperform$21Feb 3, 2026

Questions about Morgan Stanley and HBAN

What is Morgan Stanley's price target for HBAN?
Morgan Stanley's latest stated price target for Huntington Bancshares Incorporated (HBAN) is $19, from its action on Jul 24, 2026.
What is Morgan Stanley's rating on HBAN?
Morgan Stanley rates HBAN Equal-Weight, a neutral rating, as of Jul 24, 2026.
When did Morgan Stanley last change its view on HBAN?
On Jul 24, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $19.
How does Morgan Stanley's HBAN target compare with other analysts?
Across 6 firms with a HBAN price target in the last 12 months, the median target is $19. Morgan Stanley's target matches it.

More HBAN rating histories

All Morgan Stanley ratingsHBAN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.